Phenazopyridine

Legal status and availability in the UK

In our online pharmacy, phenazopyridine is available without a prescription, with discreet delivery to the United Kingdom in 9–21 days.

Basic phenazopyridine information

• INN (international nonproprietary name): Phenazopyridine.
• ATC code: G04BX06.
• Forms and strengths: tablets, typically 100 mg and 200 mg.
• Registration status in the United Kingdom: Not licensed.
• OTC / Rx classification: Supply is subject to UK medicines regulations; ask a pharmacist.

Clinical effectiveness in the UK

Can a tablet ease the immediate pain so you can get through the day?

Phenazopyridine is used as an adjunct for symptomatic relief of cystitis-related dysuria, not as definitive therapy for infection, and can reduce pain within hours.

However, when used beyond 48 hours or without appropriate antibiotic therapy phenazopyridine can mask worsening infection and delay care.

Use is usually limited to 48 hours, with standard adult dosing of 100–200 mg three times daily.

• Pharmacist safety check: Ask about recent eGFR, G6PD status, pregnancy and concurrent antibiotics.
• Pharmacist safety check: Confirm duration of symptoms and advise max 48 hours if an antibiotic is started.
• Pharmacist safety check: Warn about urine discolouration and interference with urine tests.

Indications and expanded uses

What is phenazopyridine actually for, and when should you see a specialist?

Phenazopyridine is used only for symptomatic relief of dysuria in lower urinary tract conditions such as cystitis and urethritis.

It is not an antimicrobial and should not be used instead of appropriate antibiotic therapy for bacterial infection.

It is occasionally used for short-term palliation of painful haematuria or post-procedural urinary pain, though evidence is limited.

The clinical caveat is consistent: use should be time-limited to avoid masking progressive infection, with a maximum of 48 hours when co-prescribed with antibiotics.

When to refer to urology: persistent frank haematuria, systemic signs such as fever or rigors, or failure to respond to first-line care.

Composition and brand landscape

What does the product contain?

The active ingredient is phenazopyridine, sometimes listed as phenazopyridine hydrochloride on packaging.

Phenazopyridine is not licensed in the UK, so there are no UK-licensed brands.

• Packaging notes: Warnings about orange/red urine and short-term use are routine.

Contraindications and special precautions

Who should not take this medicine, and what checks must a pharmacist make?

Absolute contraindications include significant renal insufficiency, severe hepatic impairment, G6PD deficiency, hypersensitivity to phenazopyridine, and generally paediatric use is not recommended.

Relative cautions apply in older adults, pregnancy and breastfeeding where benefits must be weighed against uncertain safety data.

Pharmacists should ask about recent eGFR results if available, any history of G6PD deficiency, pregnancy status and current antibiotics before supplying urinary analgesic tablets.

Patients must be warned about harmless orange urine that can stain clothing and about possible dizziness affecting driving.

Important laboratory note: phenazopyridine can interfere with colourimetric urine dipstick assays and may affect urinalysis interpretation.

• Consultation checklist: Check renal function, ask about G6PD, confirm pregnancy status, review concurrent medicines and advise duration limits.

Dosage guidelines

How much should be taken, and for how long?

Standard adult dosing is 100–200 mg orally three times daily after meals.

The maximum recommended duration is generally two days when phenazopyridine is used with antibacterial therapy to avoid masking infection.

Children: use is not recommended and is generally contraindicated.

Elderly patients should start at the lower end of dosing and have renal function monitored where possible.

Missed dose: Take as soon as remembered unless close to the next dose; do not double up.

Overdose: Seek urgent medical attention; risks include methemoglobinaemia and haemolysis.

Interactions overview

Could this tablet affect other medicines or tests the clinician relies on?

Phenazopyridine has few classic pharmacokinetic drug interactions but can interfere with urine dipstick and colourimetric assays, creating false results or obscuring dipstick interpretation.

Concomitant nephrotoxins or other renally cleared agents should prompt caution because accumulation increases the risk of adverse effects.

Co-prescription with oxidising agents in susceptible individuals increases the theoretical risk of methemoglobinaemia, especially in G6PD deficiency.

Clinicians are asked to report suspected interactions and adverse reactions via the MHRA Yellow Card scheme.

• Interactions to check: Renally cleared drugs, oxidising agents, and any medication affecting haemoglobin stability.
• Laboratory implication: Expect urine colour changes and possible dipstick interference that may invalidate tests.

Comparable medicines and preferences

What are the alternatives and how to choose between them?

Phenazopyridine provides local bladder analgesia while alternatives focus on systemic analgesia, antispasmodics or treating the underlying infection.

NHS first-line symptomatic measures include NSAIDs such as ibuprofen and simple self-care (fluids, analgesia); evidence for cranberry is weak.

Antibacterial treatment is required for confirmed bacterial UTI and first-line agents include nitrofurantoin and fosfomycin as per UK guidance.

• Counselling prompt: Advise when antibiotics are indicated and when to refer urgently (fever, flank pain, persistent severe symptoms).

Frequently asked questions

Will phenazopyridine treat my UTI?

No — phenazopyridine relieves pain only; antibiotics are needed to treat a bacterial infection.

How long can I take phenazopyridine?

Typically up to 48 hours when used with antibiotics; longer use risks masking a severe infection.

Why is my urine orange or red?

Orange or red urine is an expected, harmless effect and can stain clothing and affect urine tests.

Can I drive or drink alcohol while taking it?

Driving is generally safe unless you experience dizziness; avoid heavy alcohol while unwell and monitor for side effects.

Who should avoid phenazopyridine?

Those with significant kidney disease, severe liver disease, G6PD deficiency, children or known allergy should avoid it.

Guidelines for proper use

How should a pharmacist structure the consultation so patients get safe, useful relief?

Begin by confirming the indication and duration of symptoms and whether antibiotics have been started or are planned.

Perform safety checks: ask about renal history, G6PD deficiency, pregnancy, current medications and recent urine tests.

Explain dosing clearly: 100–200 mg three times daily after meals and that use should usually be no longer than 48 hours with antibiotics.

Advise on red flags that require GP or urgent care referral such as fever, loin pain or persistent haematuria.

Document rationale on electronic prescriptions and avoid repeats; provide a short patient leaflet that lists expected urine discolouration and monitoring advice.

• Suggested pharmacy counselling wording: "This tablet will ease the burning but it does not treat infection; if symptoms persist beyond two days or you develop fever, see a GP."
• Yellow Card prompt: Report any suspected serious adverse reaction such as methemoglobinaemia or haemolysis to the MHRA Yellow Card scheme.

Delivery across the United Kingdom